Provided by Tiger Trade Technology Pte. Ltd.

Eupraxia Pharmaceuticals

7.37
+0.08501.17%
Volume:342.22K
Turnover:2.51M
Market Cap:484.19M
PE:-7.39
High:7.46
Open:7.31
Low:7.13
Close:7.28
52wk High:9.32
52wk Low:5.05
Shares:65.74M
Float Shares:54.50M
Volume Ratio:0.94
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9967
EPS(LYR):-1.0300
ROE:-66.70%
ROA:-43.66%
PB:4.76
PE(LYR):-7.15

Loading ...

Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis Patients

GlobeNewswire
·
Aug 13

Eupraxia Pharmaceuticals Q2 EPS $(0.23), Inline

Benzinga Earnings
·
Aug 12

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 12

Eupraxia Pharmaceuticals files $300M mixed securities shelf

TIPRANKS
·
Aug 06

David Martin Reiterates Buy on Eupraxia Pharmaceuticals, Citing Strong KOL Support for EP-104GI’s Commercialization Potential

TIPRANKS
·
Aug 03

Eupraxia Pharmaceuticals: Buy Rating Backed by EP-104GI’s Seamless Fit Into GI Practice and Strong Commercial Outlook

TIPRANKS
·
Jul 31

Top Premarket Decliners

MT Newswires Live
·
Jul 28

Buy Rating Reaffirmed on EPRX as EP-104GI Catalyst Nears and $16 Price Target Remains Unchanged

TIPRANKS
·
Jul 22

Cantor Fitzgerald Sticks to Their Buy Rating for Eupraxia Pharmaceuticals (EPRX)

TIPRANKS
·
Jul 20

Eupraxia Pharmaceuticals Overhauls Leadership and Operations Ahead of Key EoE Trial Milestone

TIPRANKS
·
Jul 14

Eupraxia chief scientific and operating officer Amanda Malone steps down

TIPRANKS
·
Jul 14

Eupraxia Names Jeff Millard EVP Technical Operations as Amanda Malone Steps Down COO

Reuters
·
Jul 14

Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth

GlobeNewswire
·
Jul 14

Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization

GlobeNewswire
·
Jul 07

Eupraxia Pharmaceuticals Initiated at Outperform by Oppenheimer

Dow Jones
·
Jun 26

Eupraxia Pharmaceuticals initiated with an Outperform at Oppenheimer

TIPRANKS
·
Jun 26

Eupraxia Pharmaceuticals Shareholders Back Board Slate and Auditor at June 18 AGM

TIPRANKS
·
Jun 22

Eupraxia Pharmaceuticals Sets June 18, 2026 Virtual AGM and Files May Form 6-K

TIPRANKS
·
May 30

Eupraxia Pharmaceuticals Confirms Mailing of 2026 Proxy Materials to Shareholders

TIPRANKS
·
May 30

Eupraxia Pharmaceuticals to Showcase Pipeline at Jefferies Global Healthcare Conference

TIPRANKS
·
May 29